LKQ Corporation vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 87)

LKQ Corporation

LeaderConsumer Retail

Enterprise

Nashville alternative auto parts distributor (NASDAQ: LKQ) ~$14B revenue; largest recycled/aftermarket parts provider, Pick Your Part sold Sept 2025 for $118M, Uni-Select integration competing with Copart and OEM dealers.

AI VisibilityBeta
Overall Score
A87
Category Rank
#161 of 290
AI Consensus
65%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
80
Gemini
94

About

LKQ Corporation is a Nashville, Tennessee-based distributor of alternative and specialty automotive parts and accessories — publicly traded on NASDAQ (NASDAQ: LKQ) as an S&P 500 Consumer Discretionary component — operating as the largest provider of recycled, remanufactured, refurbished, and aftermarket vehicle parts and accessories across North America and Europe through approximately 45,000 employees and 1,700+ locations in 28 countries. LKQ serves collision repairers, mechanical repair shops, auto dealers, and retail consumers with alternative auto parts that are priced 25-50% below OEM dealer prices while meeting insurance company repair standards. In 2024, LKQ generated approximately $14 billion in revenue across its three operating segments: North America (wholesale recycled and aftermarket parts to US collision shops), Europe (acquired Uni-Select 2023 and operating as Rhiag/ECP for European aftermarket parts), and Specialty (truck and SUV accessories). A defining 2025 strategic action was the September 30, 2025 completion of the sale of the Self Service segment ("Pick Your Part" consumer self-service salvage yards) for $118 million — a divestiture that sharpens LKQ's focus on wholesale and specialty operations. CEO Justin Jude, who assumed leadership in 2023, has led the portfolio rationalization strategy.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

87
Overall Score
90
#161
Category Rank
#9
65
AI Consensus
60
stable
Trend
stable
88
ChatGPT
99
80
Perplexity
99
94
Gemini
83
93
Claude
96
92
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.